Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Biosimilars Market Projected to Reach $163 Billion by 2033

Guavy AI Editorial Team
Instruments
AMGN
Share

The global biosimilars market is expected to reach USD 163.14 billion by 2033, growing at an annual rate of 18.3% from 2026 to 2033.

This forecast comes from a recent report by CMI, which also highlights the significant role that key companies such as Amgen Inc., Pfizer Inc., and Samsung Bioepis Co., Ltd. are expected to play in this growing market.

The biosimilars market is driven by emerging growth opportunities, evolving industry trends, and technological advancements, according to CMI's research methodology.

More on Stocks

Stocks just now

Nvidia Exec Daughter to Discuss Robot Partnership with LG

Stocks just now

Nvidia's Earnings Report May Be Less Important Than Vera Rubin

Stocks 1m ago

Loeb's Third Point Shakes Up Portfolio with SpaceX Bet

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy